These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3126272)

  • 1. Effect of L-threo-3,4-dihydroxyphenylserine on regional cerebral blood flow in patients with Parkinson's disease.
    Ujike H; Yamamoto M
    J Neurol Sci; 1988 Jan; 83(1):75-80. PubMed ID: 3126272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
    Ogawa N; Yamamoto M; Takayama H
    J Med; 1985; 16(5-6):525-34. PubMed ID: 3938472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M; Ogawa N; Ujike H
    J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
    Birkmayer W; Birkmayer G; Lechner H; Riederer P
    J Neural Transm; 1983; 58(3-4):305-13. PubMed ID: 6420517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
    Ogawa N; Kuroda H; Yamamoto M; Nukina I; Ota Z
    Acta Med Okayama; 1984 Jun; 38(3):301-4. PubMed ID: 6431755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
    Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [D,L-threo-3,4-dihydroxyphenylserine (D,L-threo-DOPS) treatment on the patients with Parkinson's disease or pure akinesia].
    Kondo T
    Rinsho Shinkeigaku; 1984 Mar; 24(3):280-8. PubMed ID: 6432393
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-threo-3,4-dihydroxyphenylserine treatment for gait apraxia in parkinsonian patients.
    Yoshida M; Noguchi S; Kuramoto S
    Kurume Med J; 1989; 36(2):67-74. PubMed ID: 2511378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
    Teelken AW; van den Berg GA; Muskiet FA; Staal-Schreinemachers AL; Wolthers BG; Lakke JP
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):177-88. PubMed ID: 2476157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E; Irie T; Katsube J
    Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's disease.
    Fukada K; Endo T; Yokoe M; Hamasaki T; Hazama T; Sakoda S
    Med Hypotheses; 2013 Feb; 80(2):209-12. PubMed ID: 23265352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S
    Life Sci; 1985 Feb; 36(5):435-42. PubMed ID: 3918223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a synthetic norepinephrine precursor, L-threo-3,4- dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patients.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Ueno M; Nozaki Y
    Neurosci Lett; 1990 Aug; 116(1-2):194-7. PubMed ID: 2259448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
    Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shy-Drager syndrome. Effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flow.
    Matsubara S; Sawa Y; Yokoji H; Takamori M
    J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):994-7. PubMed ID: 2283531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of L-threo-3, 4-dihydroxyphenylserine effect on motor and psychological symptoms in Parkinson's disease].
    Narabayashi H; Yokochi F; Ogawa T; Igakura T
    No To Shinkei; 1991 Mar; 43(3):263-8. PubMed ID: 1907469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
    Azuma T; Suzuki T; Mizuno R; Tsujino S; Kishimoto S; Mizuta E; Ichikawa K
    Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of L-threo-DOPS on synaptic transmission to soleus motoneuron in normal subjects and patients with Parkinson's disease.
    Nakajima Y; Kagamihara Y; Nagaoka M; Tanaka R
    Neurosci Res; 1987 Oct; 5(1):16-27. PubMed ID: 2829065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.